Cite

HARVARD Citation

    Barda, N. et al. (2021). Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet. 398 (10316), pp. 2093-2100. [Online]. 
  
Back to record